Studies have shown that targeting VEGFA can regulate the STAT3 signaling pathway to inhibit inflammation and oxidative stress, thereby delaying the progression of hyperuricemia-induced chronic dilatation renal fibrosis, improving renal failure, and reducing serum UA levels [34]. Here, STAT3 is linked to hyperuricemia.